T Furlong

FK506 in combination with methotrexate for the prevention of graft- versus-host disease after marrow transplantation from matched unrelated donors

RA Nash, LA Piñeiro, R Storb et al. · Blood · 1996 · 153 citations · Full text

Medicine, Hematology, Immunology +16

Therapy with mycophenolate mofetil for refractory acute and chronic GVHD

T Furlong, Paul J. Martin, Mary E.D. Flowers et al. · Bone Marrow Transplantation · 2009 · 106 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +5

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

Marco Mielcarek, T Furlong, Barry E. Storer et al. · Haematologica · 2015 · 105 citations · Full text

Pharmacy, Pharmacotherapy, Immunopathology +12

Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study

RA Nash, Ruth Etzioni, Rainer Storb et al. · Blood · 1995 · 95 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities

T Furlong, Rainer Storb, Claudio Anasetti et al. · Bone Marrow Transplantation · 2000 · 58 citations

Life Sciences, Immunology, Pharmacology +13